L04A — Imūnsupresanti
Imūnsupresanti (IMMUNOSUPPRESSANTS)
| Aktīvā viela | Zāļu nosaukumi |
|---|---|
| Abataceptum | Orencia |
| Acidum mycophenolicum | Myfortic |
| Adalimumabum | AMSPARITY, Amgevita, Hefiya, Hukyndra, Hulio, Humira |
| Alemtuzumabum | Lemtrada |
| Anakinrum | Kineret |
| Anifrolumabum | Saphnelo |
| Apremilastum | Apremilast Accord, Apremilast KRKA, Apremilast Stada, Imaplix, Otezla |
| Avacopanum | Tavneos |
| Azathioprinum | Atsimutin, Imuran, Jayempi |
| Baricitinibum | Olumiant |
| Basiliximabum | Simulect |
| Belatacept | NULOJIX |
| Belimumabum | Benlysta |
| Belumosudilum | Rezurock |
| Bimekizumabum | Bimzelx |
| Brodalumabum | Kyntheum |
| Canakinumabum | Ilaris |
| Certolizumabum pegolum | Cimzia |
| Ciclosporinum | Sandimmun Neoral |
| Cladribinum | Mavenclad |
| Crovalimabum | Piasky |
| Danicopanum | Voydeya |
| Deucravacitinibum | SOTYKTU |
| Dimethylis fumaras | Arbicen, Cohiber, Dimethyl fumarate ALIUD, Dimethyl fumarate Accord, Dimethyl fumarate Gedeon Richter, Dimethyl fumarate Glenmark |
| Diroximeli fumaras | Vumerity |
| Eculizumabum | Bekemv, Epysqli, Soliris |
| Efgartigimodum alfa | Vyvgart |
| Etanerceptum | Benepali, Enbrel, Erelzi, Fubelv, Nepexto |
| Etrasimodum | Velsipity |
| Everolimusum | Certican |
| Filgotinibum | Jyseleca |
| Fingolimodum | Chantico, Efigalo, Fingolimod Accord, Fingolimod MSN, Fingolimod Mylan, Fingolimod Norameda |
| Golimumabum | Gobivaz, Gotenfia, Simponi |
| Guselkumabum | Tremfya |
| Imlifidasum | Idefirix |
| Immunoglobulinum anti-T lymphocytorum ex animale ad usum humanum | Grafalon |
| Immunoglobulinum antithymocytorum ex cuniculi ad usum humanum | Thymoglobuline |
| Immunoglobulinum antithymocytorum ex equini ad usum humanum | Atgam |
| Inebilizumabum | Uplizna |
| Infliximabum | Flixabi, Inflectra, Remicade, Remsima, Zessly |
| Iptacopanum | Fabhalta |
| Ixekizumabum | Taltz |
| Leflunomidum | Arava, Leflunomide Elvim, Leflunomide Sandoz, Leflunomide Zentiva, Leflunomide medac, Leflunomide ratiopharm |
| Lenalidomidum | Lenalidomide Accord, Lenalidomide Grindeks, Lenalidomide Krka, Lenalidomide Mylan, Lenalidomide Norameda, Lenalidomide Stada |
| Methotrexatum | Ebetrex, Metex, Nordimet |
| Mirikizumabum | Omvoh |
| Mycophenolas mofetil | CellCept, Myclausen, Mycophenolate Mofetil Accord, Mycophenolate mofetil Teva, Myfenax |
| Natalizumabum | Tyruko, Tysabri |
| Nerandomilastum | Jascayd |
| Nipocalimabum | Imaavy |
| Ocrelizumabum | Ocrevus |
| Ofatumumabum | Kesimpta |
| Ozanimodum | Zeposia |
| Pegcetacoplanum | Aspaveli |
| Pirfenidonum | Esbriet, Pirfenidone Accord, Pirfenidone MSN, Pirfenidone Teva, Pirfenidone Umedica, Pirfenidone Viatris |
| Pomalidomidum | Imnovid, Pomalidomide Accord, Pomalidomide Grindeks, Pomalidomide Krka, Pomalidomide Olpha, Pomalidomide STADA |
| Ponesimodum | Ponvory |
| Ravulizumabum | Ultomiris |
| Remibrutinibum | Rhapsido |
| Risankizumabum | Skyrizi |
Kompensējamās zāles
Šajā grupā 33 ATĶ kodi ir NVD kompensējamo zāļu sarakstā. Saraksts spēkā no 01.07.2026.
NVD2izraksta ģimenes ārsts
NVD*2izraksta ģimenes ārsts, ievērojot norādītos kritērijus
NVD33izraksta speciālists
| ATĶ | Aktīvā viela | Kompensācija | Izrakstīšana |
|---|---|---|---|
| L04AA06 | Acidum mycophenolicum | 100% | NVD* NVD |
| L04AA24 | Abataceptum | 100% | NVD |
| L04AA40 | Cladribinum | 100% | NVD |
| L04AB01 | Etanerceptum | 100% | NVD |
| L04AB02 | Infliximabum | 100% | NVD |
| L04AB04 | Adalimumabum | 100% | NVD |
| L04AB06 | Golimumabum | 100% | NVD |
| L04AC03 | Anakinrum | 100% | NVD |
| L04AC05 | Ustekinumabum | 100% | NVD |
| L04AC07 | Tocilizumabum | 100% | NVD |
| L04AC10 | Secukinumabum, Secukinumabum 300mg deva, Secukinumabum 150mg deva | 100% | NVD |
| L04AC16 | Guselkumabum | 100% | NVD |
| L04AC18 | Risankizumabum 360mg un 600mg deva, Risankizumabum 150mg deva | 100% | NVD |
| L04AD01 | Ciclosporinum | 100%, 75% | NVD NVD* NVD |
| L04AD02 | Tacrolimusum | 100% | NVD |
| L04AE01 | Fingolimodum | 100% | NVD |
| L04AE03 | Siponimodum | 100% | NVD |
| L04AE04 | Ponesimodum | 100% | NVD |
| L04AF01 | Tofacitinibum | 100% | NVD |
| L04AF03 | Upadacitinibum | 100% | NVD |
| L04AF04 | Filgotinibum | 100% | NVD |
| L04AG03 | Natalizumabum | 100% | NVD |
| L04AG05 | Vedolizumabum | 100% | NVD |
| L04AG08 | Ocrelizumabum | 100% | NVD |
| L04AG12 | Ofatumumabum | 100% | NVD |
| L04AH01 | Sirolimusum | 100% | NVD |
| L04AK01 | Leflunomidum | 100% | NVD |
| L04AK02 | Teriflunomidum | 100% | NVD |
| L04AX01 | Azathioprinum | 100%, 75% | NVD NVD |
| L04AX03 | Methotrexatum | Nosacījumus skatīt pie L01BA01 | |
| L04AX04 | Lenalidomidum | 100% | NVD |
| L04AX05 | Pirfenidonum | 100% | NVD |
| L04AX07 | Dimethyl fumaratum | 100% | NVD |
| L04AX09 | Diroximeli fumaras | 100% | NVD |
Apakšgrupas
L04AA - Selektīvie imūnsupresanti
L04AB - Tumora nekrozes faktora alfa (TNF-α) inhibitori
L04AC - Interleikīnu inhibitori
L04AD - Kalcineirīna inhibitori
L04AE - Sfingozīna-1-fosfāta (S1P) receptoru modulatori
L04AF - Janus kināzes (JAK) inhibitori
L04AG - Monoklonālās antivielas
L04AH - Rapamicīna mērķa receptora zīdītājiem (mTOR) kināzes inhibitori
L04AJ - Komplementa inhibitori
L04AK - Dihidroorotāta dehidrogenāzes (DHODH) inhibitori
L04AL - Neonatal fragment crystallizable receptor (FcRn) inhibitors
L04AX - Citi imūnsupresanti
Avots: Zāļu valsts aģentūras Zāļu reģistrs · ATĶ klasifikators: data.gov.lv · kompensācija: NVD kompensējamo zāļu saraksts